Immunic, Inc.
IMUX· Nasdaq
Released Nov 7, 2024, before the open
10-Q filed Nov 7, 2024, 38 days after period end · 0001280776-24-000018
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$24.37M | -$22.77M | -$21.22M | -$19.29M |
| EPS Diluted | -$0.24 | -$0.51 | -$0.69 | -$0.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR